DAFTAR PUSTAKA
Amalinei C, Caruntu ID, Balan RA. 2007. Biology of metalloproteinases.
Romanian Journal of Morphology and Embryology 488 (4) : 323- 324.
Amalinei C et al. 2010. Matrix Metalloproteinases involvement in patologic conditions. Romanian Journal of Morphology and Embryology 51 (2) : 215-218.
Anolik A. 2010. Fluticasone furoate nasal spray : Profile of an enhanced-affinity corticosteroid in treatment of seasonal allergic rhinitis. Journal of asthma and allergy 3: 87-99.
Aouad, R K; Chiu, A G. 2011. “State of the art treatment of nasal polyposis.” American journal of rhinlogy & allergy 25, 291-298.
Assanasen, P & Naclerio, RM. 2001. Medical and Nasal surgical management of nasal polyps in Current opinion in Otolaryngology and Head and Neck Surgery. Lippincott William and Wilkins Inc, p. 27-36.
Bachert, C. 2011. “Evidence- based management of nasal polyposis by intranasal corticosteroid: from the cause to the clinic.” Int arch allergy immunol, 155:309-321.
Bachert, C; Watelet, JB; Gevaert, P; Cauwenberge, PV. 2005. ”Pharmacological Management of Nasal Polyposis.” Journal of Drugs evaluation 66 (1): 1537-1552.
Badia, L; Lund, V. 2001. “Topical corticosteroid in nasal polyposis.” Review article, drugs ; 61(5) 573-578.
Bugdayci, G; Kaymakci, M; Bukan, N. 2008. “Matrix metalloproteinase-9 (MMP-9) in allergic nasal polyps.” Acta histochemica 112 : 92-95. Burgel PR, Cardell LO, Ueki IF. 2004. “Intranasal steroids decrease
Callejas, F B et al. 2014. “Corticosteroid treatment regulates mucosal remodeling in chronic rhinosinusitis with nasal polyps.” Laryngoscope 25147.
Cao & Zucker. 2007. Biology and Chemistry of matrix metalloproteinases (MMPs).
Chen, Y S; Langhammer, T; Westhofen, M; Lorenzen, J. 2007. “Relationship between matrix metalloproteinases MMP-2, MMP-9, tissue inhibitor of matrix metalloproteinases-1 and IL-5, IL-8 in nasal polyps.” Allergy volume 62, issue 1, p.66-72.
Chi, A H; Annette. 2005. “ Nasal polyposis: an immunohistochemical study of cell cycle regulator proteins in epithelial proliferation.” A thesis submitted for the degree of master of science.
Cincik, H et al. 2013.” Evaluation of MMP-9 and TIMP-1 levels of the patients with nasal polyposis after corticosteroid therapies.” Indian J Otolaryngol Head Neck Surg, 65: s445-s449.
Cohen, S; Ben Efraim, A N; Levi-Schaffer, F; Eliashar, R. 2011. “The Effect of hypoxia and cycloxygenase inhibitors on nasal polyp derived fibroblasts.” American journal of otolaryngology-Head and Neck Medicine and Surgery 32. 564-573
Dewi, F. 2011. Profil Polip Nasi di RSUP H. Adam Malik Medan Tahun 2010. Tesis Spesialis Ilmu Kesehatan Telinga, Hidung, Tenggorok, Bedah Kepala dan Leher. FK USU
Djupesland, P G; Vlckova, I; Hewson G. 2010. “Impact of baseline nasal polyp size and previous surgery on efficacy of fluticasone delivered with a novel device: A subgroup analysis.” American journal rhinol, 24.3516.
Guerra, G; Testa, D; Marcuccio, G; D´Errico, G; Cianchetta, M R; Cinelli, M; Russo, A; Montagnani, S. 2012. “TIMPs and MMPs expression in nasal polyps.” Italian journal of anatomy and embryology, vol 117, n. 2: 87.
balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma. J Allergy Clin Immunol. 1999;104:356–363. doi: 10.1016/S0091-6749(99)70379-9.
Hwang, PH; Abdalkhani, A. 2009. Embryology, Anatomy and Physiology of the Nose and Paranasal Sinuses in: Ballenger‟s Otorhinolaryngology and Head and Neck Surgery. BC Decker Inc, Ontario, 17th ed, vol 4, p. 455-463
Irfan, M & Shamim, AK 2009,‟Routine Histological Examination for Nasal Polyp Specimens: Is it Necessary ?‟,Med J Malaysia,vol.1, hal. 59-60.
Joe SA, Thambi R & Huang J 2008,‟ A systematic review of the use of intranasal steroids in the treatment of chronic rinosinusitis,” Otolaryngol Head Neck Surg 139:340-347
Kahveci, O K; Derekoy, F S; Yilmaz, M D; Serteser, M; Altuntas, A. 2008. The role of MMP-9 and TIMP-1 in nasal polyp formation. Swiss med wkly;138 (45-46) : 684-688
Kostamoa K, Toskalab E, Tervahartiala T, Sorsa T. Role of matrix metalloproteinases in chronic rhinosinusitis. Curr Opin Allergy Clin Immunol. 2008;8:21–27. doi: 10.1097/ACI.
Kuzminski, A; Przybyszewski, M; Graczyk, M; Bartuzi, Z. 2012. ”The role of extracellular matrix metalloproteinases and their inhibitors in allergic diseases.” Postep derm alergol,XXIX,5:384-389.
Lechapt-Zalcman E, Coste A, d‟Ortho MP, et al. Increased expression of matrix metalloproteinase-9 in nasal polyps. J Pathol. 2001;193:233– 241.
Mangunkusumo, E dan Wardani, RS. 2007. Polip Hidung dalam: Buku Ajar Ilmu Kesehatan Telinga, Hidung Tenggorok, Kepala dan Leher. Balai Penerbit FKUI, Jakarta, edisi keenam, h. 123-5.
Munir, D 2008,„Histopathology Types of Polyposis in Adam Malik Hospital‟, Majalah Kedokteran Nusantara, vol.1, hal. 1-3.
Mygind, N; Lund, V J. 2008. Nasal polyposis in: Scott-Brown´s Otorhinolaryngology, Head and Neck Surgery. Hodder Arnold, 7th ed, vol 2, p. 1549-1557
Pawankar R, Watanabe S, Nonaka M, Ozu C, Aida M, Yagi T. Differential expression of matrix metalloproteinase 2 and 9 in the allergic nasal mucosa and nasal polyps. J Allergy Clin Immunol. 2004;113:1229. doi: 10.1016/j.jaci.2004.01.701.
Pearlman, A N; Chandra, R K; Conley, D B; Kern, R C. 2010. Epidemiologi of nasal polyps in: Nasal polyposis. Springer- Verlag Berlin.
PERHATI-KL. 2007. Algoritma Penatalaksanaan Polip Hidung dan Sinus Paranasal (Dewasa) dalam: Guideline penyakit THT-KL di Indonesia. Product monograph avamys ® fluticasone furoate nasal spray 27.5
mcg/metered spray Corticosteroid for nasal use. 2015
Ryan, M W. 2014. Chronic Rhinosinusitis with nasal polyposis in: Bailey´s Head and Neck Surgery. Lippincott Williams & Wilkins, 5th ed, part 1, p.525-547.
Sauter, A; Stern- Straeter, J; Sodha, S; Hormann, K; Naim, R. 2008. “Regulation of matrix metalloproteinases (MMP)-2/-9 expression in eosinophilic chronic rhinosinusitis cell culture by interleukin5 and -13.” In vivo 22:415-422.
Schlosser, R J; Woodworth, B A. 2009. Chronic Rhinosinusitis and Polyposis in: Ballenger´s Otorhinolaryngology and Head and Neck Surgery. BC Decker Inc, Ontario, 17th ed, vol 4, p. 573-582
Sembiring, E S. 2014. “Perbandingan efek terapi fluticasone furoate semprot hidung dan metil prednisolon oral pada polip hidung dinilai dari perubahan jumlah sel radang dan stadium polip hidung.”
Soetjipto, D; Mangunkusumo, E; Wardani, RS. 2007. Hidung dalam: Buku Ajar Ilmu Kesehatan Telinga, Hidung, Tenggorok, Kepala dan Leher. Balai Penerbit FKUI, Jakarta, edisi keenam, h. 118-22.
Storms, W; Yawn, B; Fromer, L. 2007. Therapeutic options for reducing sleep impairment in allergic rhinitis, rhinosinusitis, and nasal polyposis in: Current medical research and opinions, vol 23, no.9, p. 2135-46.
S, De; Fenton, J E; Jones, A S. 2005. “ Matrix m etalloproteinases and their inhibitors in non- neoplastic otorhinolaryngological disease.” The journal of laryngology and otology 119.6: 436-42.
Takeuchi, K; Majima, Y. 2005. “Remodeling in chronic sinusitis and nasal polyps.” Allergology International, 54:39-4.
Topal, O; Erbek, SS; Kiyici, H; Cakmak O. 2008. Expression of metalloproteinases MMP-9 in antrochoanal polyps. American Journal of Rhinology 22 : 339-342
Wang, L F; Chien, C Y; Chiang, F Y; Chai, C Y; Tai, C F. 2012. “Corelationship between matrix metalloproteinase 2 and 9 expression and severity of chronic rhinosinusitis with nasal polyposis.” American journal of rhinology & allergy 26, e1-e4.
